Hans Ibsen

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Hypertension, Cardiovascular Disease, Endpoint Reduction +7

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars Lindholm, Hans Ibsen, Björn Dahlöf et al. · The Lancet · 2002 · 1.6K citations

Hypertension, Cardiovascular Disease, Health Policy +9

Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population

Tine W. Hansen, Jan A. Staessen, Christian Torp‐Pedersen et al. · Circulation · 2006 · 1.5K citations · Full text

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

José Boggia, Yan Li, Lutgarde Thijs et al. · The Lancet · 2007 · 860 citations · Full text

Blood Pressure Monitoring, Hypertension, Cardiovascular Disease +8

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Kristian Wachtell, Mika Lehto, Eva Gerdts et al. · Journal of the American College of Cardiology · 2005 · 821 citations

Thrombosis, Hypertension, Cardiovascular Disease +14